EPM's scoring engine was validated against four consecutive years of national substance use treatment data — the Treatment Episode Data Set published by SAMHSA. Same engine, same math, four independent years. It held. The validation cohort was specific: opioid-primary patients in IOP programs, community-dwelling, measured on real treatment outcomes. Not a simulation. Not a mixed population.
OQ-45
SUD treatment outcome
0.62 AUC
0.80–0.84 AUC
ASI Composite
SUD relapse prediction
0.75 AUC
0.80–0.84 AUC
COMPAS
Recidivism · 137 variables
0.71 AUC
0.716 AUC
12 vars · zero racial inputs
C-SSRS
Suicide risk sensitivity
13%
93%
SUD: four years TEDS-D federal data, N=103,168, opioid IOP clean cohort, 2020–2023. Recidivism: NIJ Challenge, cold — no training on this data. C-SSRS: 15-case head-to-head. EPM outperforms on every domain measured.
108/100
When the math breaks 100 — that's not a bug. That's a signal.
EPM scores can exceed 100 or go negative. A stability score of 108 means a patient is performing beyond the standard ceiling — exceptional engagement, exceptional support, exceptional trajectory. A negative trajectory score means the decline is accelerating faster than the baseline model predicts. The math doesn't cap reality to fit a scale. It reflects what's actually happening. That's the point.
Patent Pending · US App 64/063,351 · 108 claims
EPM Clinical is clinical decision support software. Scores surface information for clinician review. Clinicians retain all clinical decision authority. Not an FDA medical device.